Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Biopharma's LDL Cholesterol-Lowering Drug Emerges as 'Lead Stallion in Safety'

The interim study results for an in-progress trial evaluating this asset are discussed in a ROTH Capital Partners report. Beaker In a May 20 research report, ROTH Capital Partners analyst Yasmeen Rahimi reported that The Medicines Company's (MDCO:...
Streetwise Reports | May 30, 2019 |

Shares Rise as The Medicines Company Reports Positive Topline Results...

Shares Rise as The Medicines Company Reports Positive Topline Results from Two Phase 3 Cholesterol Trials The Medicines Company's shares are trading 8.5% higher today after the firm reported positive results from two phase 3 studies for inclisiran, one for familial hype...
Streetwise Reports | September 26, 2019 |

Topline Results from Lipid-Lowering Trial 'Just What the Doctor Ordered'

The study data and their implications are provided in a BTIG report. In an Aug. 29 research note, BTIG analyst Thomas Shrader reported that just released topline data are "as hoped" from Esperion Therapeutics Inc.'s (ESPR:NASDAQ) Phase 2 trial of bempedoic acid-ezet...
Streetwise Reports | September 5, 2019 |

Amarin Shares Up Sharply on Increased Revenues and Vascepa's Progress

Amarin shares are spiking up today by more than 12% on greater than five times 50-day average volume after the company updated its annual revenue forecast and plans for Vascepa. Amarin Corp. (AMRN:NASDAQ) ADR shares are up sharply today after the com...
Streetwise Reports | July 3, 2019 |

The Dollar Will NOT Crash

I said it! That’s correct, the FED is strengthening the Dollar. Today we will discuss the definition of a Dollar, composition of Federal Reserve Note, what the Constitution states regarding money, and how you may bene...
Maurice Jackson | April 9, 2020 |

FDA Grants Breakthrough Status to Biopharma's Lead Candidate for Liver Disease

The California firm's most advanced asset is advancing through Phase 2b, according to a ROTH Capital Partners report. In a Feb. 19 research note, analyst Yasmeen Rahimi reported that CymaBay Therapeutics Inc. (CBAY:NASDAQ) is having a strong Q1/19 with respect to cont...
Streetwise Reports | February 26, 2019 |

Top Penny Stocks – January 2020

Before offering investors some basic tips on how to buy penny stocks, definition of terms is in order. What is a penny stock? The general definition is that a penny stock is any stock with a share price below one dollar. Typically, though not necessarily, penny stocks ar...
Stockhouse Editorial | July 24, 2019 |

Tocvan: Drill, Brodie, Drill

When management changes at a junior resource company it often worries shareholders. Is there a “problem”? Mark Smethurst has stepped down as the COO of Tocvan Ventures ( CSE: TOC ) but remains a director of the company. Brodie Sutherland has ...
Jay Currie | December 10, 2020 |

The Gold Play That’s Poised for a Breakout 2022

With the spot price of gold hovering around USD$2000 and inflation soaring, savvy metals & mining investors are looking for real value and opportunity in the precious metals exploration space. And, it’s gold that has historically provided the most proven tra...
Dave Jackson | April 27, 2022 |

New technology to screen for security threats

Liberty Defense Holdings ( TSXV:SCAN ) ( OTCQB:LDDFF ) has spent USD$30 million over the last two years developing a next generation threat detection solution for the aviation and the urban security market. The company recently announced sales and is making progress on a ...
Brieanna McCutcheon | May 15, 2023 |
1 2 3 4 5 6 7 8 9 10